Stock AYTU AYTU BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Aytu BioPharma, Inc.

Equities

AYTU

US0547548588

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-24 EDT 		5-day change 1st Jan Change
3.2 USD +0.63% Intraday chart for Aytu BioPharma, Inc. +8.84% +12.68%
05-15 Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024
05-15 Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q3 Revenue $18M, vs. Street Est of $17.4M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AYTU BIOPHARMA, INC. Stock Aytu BioPharma, Inc.
 17.82M - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 727B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 599B
JOHNSON & JOHNSON Stock Johnson & Johnson
 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
 328B
ABBVIE INC. Stock AbbVie Inc.
 277B
  1. Stock Market
  2. Equities
  3. AYTU Stock
  4. Charts Aytu BioPharma, Inc.
  5. Sector Chart